Valuation : Ipca Laboratories Limited

Market Cap 495B 5.18B 4.46B 4.18B 3.82B 7.19B 7.22B 49.63B 19.36B 250B 19.44B 19.01B 828B P/E 2027 *
32.6x
P/E 2028 * 27.9x
Enterprise Value 484B 5.07B 4.37B 4.09B 3.74B 7.04B 7.06B 48.56B 18.95B 244B 19.02B 18.61B 810B EV / Sales 2027 *
4.4x
EV / Sales 2028 * 3.87x
Free-Float
54.94%
Yield 2027 *
0.3%
Yield 2028 * 0.32%
1 day-0.48%
1 week+2.05%
Current month+11.59%
1 month+9.91%
3 months+27.94%
6 months+27.56%
Current year+37.45%
1 week 1,898
Extreme 1898
1,992
1 month 1,674.4
Extreme 1674.4
1,992
Current year 1,391.8
Extreme 1391.8
1,992
1 year 1,251.6
Extreme 1251.6
1,992
3 years 856.8
Extreme 856.8
1,992
5 years 669.8
Extreme 669.8
1,992
10 years 200
Extreme 200
1,992
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-31
Chief Executive Officer 70 2023-03-31
Chief Tech/Sci/R&D Officer 52 2023-10-15
Director TitleAgeSince
Chairman 79 2012-07-04
Director/Board Member 53 2008-11-10
Director/Board Member 70 1994-07-31
Date Insider Type Main position Quantity % Market Cap.
12/19/24 Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
-0.48%+2.05%+40.88%+119.53% 5.18B
-0.13%-6.44%+60.34%+112.06% 1,047B
+0.85%-0.81%+51.29%+63.13% 646B
-1.03%-3.58%+21.43%+73.10% 451B
-1.46%-4.50%+37.80%+37.41% 355B
-0.72%-2.89%+22.32%+36.62% 291B
-1.19%-2.21%+1.53%+10.79% 252B
-1.05%-1.57%+50.30%+66.55% 234B
+0.08%-1.78%-17.64%-54.36% 203B
-2.14%-0.30%+28.95%+86.27% 181B
Average -0.73%-2.20%+29.72%+55.11% 366.45B
Weighted average by Cap. -0.46%-3.45%+38.17%+65.08%

Financials

2027 *2028 *
Net sales 110B 1.15B 991M 929M 848M 1.6B 1.6B 11.03B 4.3B 55.5B 4.32B 4.23B 184B 123B 1.28B 1.11B 1.04B 947M 1.78B 1.79B 12.3B 4.8B 61.92B 4.82B 4.71B 205B
Net income 15.15B 158M 137M 128M 117M 220M 221M 1.52B 593M 7.65B 595M 582M 25.35B 17.8B 186M 160M 150M 137M 259M 260M 1.78B 696M 8.98B 699M 684M 29.79B
Net Debt -10.65B -111M -96.02M -90.03M -82.18M -155M -155M -1.07B -417M -5.38B -418M -409M -17.83B -19.96B -209M -180M -169M -154M -290M -291M -2B -781M -10.07B -784M -767M -33.4B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
26-08-28 ₹1,950.30 -0.48% 276,397
26-08-27 ₹1,959.80 +0.38% 122,184
26-08-26 ₹1,952.40 +1.24% 455,426
26-08-25 ₹1,928.50 +0.42% 427,720
26-08-24 ₹1,920.40 +0.48% 277,434
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,950.30INR
Average target price
1,972.28INR
Spread / Average Target
+1.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IPCALAB Stock